High blood pressure trials in China

In China 130 Also abroad 847

130 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Where
Baotou, Beijing, Changchun, Changsha, Changzhou, Chengdu, Chongqing, Dongwan, Fuyang, Guangzhou, Haikou, Hefei, Hengyang, Heze, Huaian, Jiaxing, Jilin City, Jinan, Jinhua, Jining, Lanzhou, Linhai, Linyi, Luoyang, Nanchang, Nanning, Ningbo, Panjin, Pingxiang, Shanghai, Shantou, Shenyang, Shenzhen, Suzhou, Taian, Tianjin, Wanzhou, Wuhan, Wuxi, Xi'an, Xianyang, Yantai, Yinchuan, Zhengzhou, Zhongshan, Zhuzhou, Zigong
Age
18 years and over
People
5,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT06742723 · EU 2023-506460-14-00
No phaseNot yet taking people in China
Household Salt Substitution for Hypertension Prevention and Control: The HOME-Salt Trial
Where
Shihezi
Age
18 years and over
People
800
Run by
Shihezi University
See details and how to joinNCT07840742
Phase 3Taking people
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Where
Baotou, Beijing, Changchun, Changsha, Changzhou, Chengdu, Chongqing, Dalian, Fuzhou, Guangzhou, Guiyang, Haikou, Hangzhou, Harbin, Hefei, Huizhou, Jiangmen, Jinan, Jining, Jinzhou, Lanzhou, Lishui, Luoyang, Macau, Nanchang, Nanjing, Nanning, Nantong, Nanyang, Ningbo, Pingxiang, Qinhuangdao, Shanghai, Shenyang, Siping, Suzhou, Tianjin, Wenzhou, Wuhan, Xiamen, Xi'an, Xiangyang, Xianyang, Xuancheng, Xuzhou, Yinchuan, Zhenjiang, Zibo
Age
18 years and over
People
11,800 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00
No phaseNot yet taking people in China
Chinese Overweight/Obesity Cohort: Metabolic & Comorbidity Risks
Where
Taiyuan
Age
18 years to 79 years
People
25,974
Run by
Shanxi Bethune Hospital
See details and how to joinNCT07884903
No phaseTaking people
A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
Where
Fuzhou, Jinan, Nanjing, Xiamen
Age
18 years to 85 years
People
750 worldwide
Run by
Pulnovo Medical, Inc.
See details and how to joinNCT07214376
Phase 2/3Taking people
A Trial of HRS-1780 in Participants With Uncontrolled Hypertension or Resistant Hypertension.
Where
Chongqing, Shanghai
Age
18 years to 80 years
People
914
Run by
Shandong Suncadia Medicine Co., Ltd.
See details and how to joinNCT07708441
No phaseTaking people
An Extension Trial of GW 906 in Participants With Essential Hypertension
Where
Shanghai
Age
18 years and over
People
1,500
Run by
Shenzhen Salubris Pharmaceuticals Co., Ltd.
See details and how to joinNCT07879755
Phase 3Taking people
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Where
Beijing, Binhai, Changchun, Changsha, Chengdu, Chenzhou, Chifeng, Chongqing, Dalian, Datong, Foshan, Fuzhou, Guangzhou, Haidian, Haikou, Handan, Hangzhou, Hefei, Huaian, Huainan, Jiaxing, Jinan, Kaifeng, Kunming, Lanzhou, Lianyungang, Lishui, Luoyang, Luzhou, Nanchang, Nanjing, Nanyang, Pingxiang, Shanghai, Shenyang, Shijiazhuang, Taian, Taiyuan, Tangshan, Tianjin, Ürümqi, Wenzhou, Wuhan, Xianyang, Xinxiang, Xuancheng, Xuzhou, Yangzhou, Yantai, Yuncheng, Zhenjiang, Zibo
Age
18 years and over
People
11,000 worldwide
Run by
Alnylam Pharmaceuticals
See details and how to joinNCT07181109 · EU 2025-522960-34-00
Phase 3Taking people
A Phase IIIb Study to Investigate the Effect of Baxdrostat in Chinese Participants With Uncontrolled Hypertension.
Where
Beijing, Bengbu, Changchun, Changsha, Chengdu, Chongqing, Foshan, Fuzhou, Guangzhou, Haikou, Hangzhou, Jinan, Kunming, Lanzhou, Lu'an, Nanchang, Nanjing, Nanning, Ningbo, Qingdao, Shanghai, Shantou, Shenyang, Shenzhen, Shijiazhuang, Suzhou, Taiyuan, Taizhou, Tianjin, Ürümqi, Wuhan, Xi'an, Yinchuan, Zhengzhou
Age
18 years and over
People
286
Run by
AstraZeneca
See details and how to joinNCT07686120
No phaseTaking people
The Effect of Ablation Duration of Renal Denervation on Antihypertensive Efficacy
Where
Shanghai
Age
20 years to 80 years
People
220
Run by
Ruijin Hospital
See details and how to joinNCT07876479
Phase 4Taking people
Sitogilun Malate Plus Amlodipine in Patients With Hypertension and Risk of Early Kidney Damage
Where
Shanghai
Age
18 years and over
People
456
Run by
Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT07876544
Phase 3Enrolling by invitation
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
Where
Beijing, Changsha, Guangzhou, Shanghai
Age
18 years and over
People
1,000 worldwide
Run by
United Therapeutics
See details and how to joinNCT03683186 · EU 2023-509305-68-00
No phaseTaking people
Taining Golden Lake Comprehensive Chronic Disease Management Initiative
Where
Fuzhou
Age
18 years and over
People
20,000
Run by
First Affiliated Hospital of Fujian Medical University
See details and how to joinNCT07308314
No phaseTaking people
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Where
Nanjing
Age
18 years and over
People
316 worldwide
Run by
Orchestra BioMed, Inc
See details and how to joinNCT06059638
Phase 4Taking people
Effect of the Traditional Chinese Medicine Yufeng Ningxin in Patients With Hypertension
Where
Beijing, Chongqing, Dalian, Hohhot, Longyan, Luohe, Nanchang, Nanjing, Shantou, Taiyuan, Tianjin, Wuhan, Xiamen
Age
18 years to 65 years
People
350
Run by
Beijing Anzhen Hospital
See details and how to joinNCT07607275
Phase 3Taking people
Phase III Study of HRS-7535 for Hypertension With Overweight or Obesity
Where
Beijing, Harbin
Age
18 years to 70 years
People
648
Run by
Shandong Suncadia Medicine Co., Ltd.
See details and how to joinNCT07528027
Phase 2Not yet taking people in China
A Study to Evaluate Efficacy and Safety of GW906 Used as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by One or Two Antihypertensive Medications
Where
Hangzhou
Age
18 years and over
People
560
Run by
Shenzhen Salubris Pharmaceuticals Co., Ltd.
See details and how to joinNCT07835984
Phase 2Not yet taking people in China
A Phase II Study of VB19055 in Uncontrolled or Resistant Hypertension
Where
Baotou, Beijing, Changsha, Chengdu, Chongqing, Daqing, Hebei, Hengyang, Jining, Luoyang, Nanjing, Panjin, Shandong, Shanghai, Shaxi, Shenyang, Suzhou, Wuhan, Xinxiang, Zhengzhou
Age
18 years and over
People
240
Run by
Zhejiang Yangli Pharmaceutical Technology Co., Ltd.
See details and how to joinNCT07833098
No phaseNot yet taking people in China
EECP for Erectile Dysfunction in Elderly Hypertensive Patients
Where
Jinan, Shenzhen
Age
60 years to 75 years
People
106
Run by
Qilu Hospital of Shandong University
See details and how to joinNCT07831551
No phaseTaking people
Polypills Approach for Multiple Cardiovascular Risk Factors
Where
Chifeng, Jinan, Jinzhou, Kunshan, Panjin, Shenyang, Suzhou, Taizhou, Tieling, Tongliao, Zhengzhou
Age
50 years to 75 years
People
8,252
Run by
China Medical University, China
See details and how to joinNCT07679828
No phaseTaking people
A Cluster-Randomized Trial of a Hypertension Risk Model-Based Precision Intervention in High-Risk Adults in Shunyi District
Where
Beijing
Age
35 years to 65 years
People
500
Run by
Peking University
See details and how to joinNCT07804420
No phaseTaking people
A Prospective Nurse Cohort Study in Xiamen, China
Where
Xiamen
Age
20 years and over
People
10,000
Run by
The First Affiliated Hospital of Xiamen University
See details and how to joinNCT03799653
Phase 1Taking people
Phase 1 Clinical Study of MWX401 Injection in Chinese Healthy Participants and Participants With Mild Hypertension
Where
Nanjing
Age
18 years to 60 years
People
46
Run by
Shanghai Minwei Biotechnology Co., Ltd
See details and how to joinNCT07803835
No phaseTaking people
Salt Sensitivity Evaluation Via N-of-1 Trials (SENSE-Salt)
Where
Beijing
Age
20 years to 65 years
People
72
Run by
Peking University
See details and how to joinNCT07614724
No phaseTaking people
A Novel Rural Integrated Care and Early Prevention Model for Older Adults at High Risk of or Living With Stroke in China
Where
Suqian
Age
65 years and over
People
2,510
Run by
Jiangsu Province (Suqian) Hospital
See details and how to joinNCT07628283